Levonorgestrel 30mcg (Microlut): Supply issue
Levonorgestrel 30 mcg (Microlut) is a progestogen-only contraceptive.
The supplier, Bayer New Zealand Ltd, has advised there are currently shortages of Microlut.
PHARMAC has listed an alternative levonorgestrel tab 30 mcg product (brand name Microlut SCT) on the Pharmaceutical Schedule.
Microlut SCT is also supplied by Bayer New Zealand Ltd. Medsafe has approved it for sale in New Zealand.
On this page
- Brand availability
- Same active ingredients and strength
- Information for people taking Microlut
- Information for prescribers
- Information for pharmacists
Bayer advises that Microlut SCT will be available in late May and Microlut will be back in stock in early August.
This means that anybody changing from Microlut to an alternative product would only need to do so temporarily.
The active ingredients and strength of Microlut SCT are the same as Microlut. However, Microlut SCT has slightly different packaging and product information from Microlut because it is from Australia.
- has the same active ingredients at the same strength as Microlut
- is made by the same company as Microlut
- has slightly different packaging from your usual Microlut.
If you have any questions about Microlut SCT, we recommend you talk to your prescriber or pharmacist.
Alternative funded progestogen-only contraceptives are listed on the Pharmaceutical Schedule. They include Microlut SCT, which was listed as an alternative to Microlut on 20 May.
Microlut SCT was initially approved under section 29 of the Medicines Act 1981. Medsafe has since approved it for sale in New Zealand.
The Pharmaceutical Schedule will not reflect this change until it is updated for 1 July 2020.
Advice on prescribing contraceptives
BPAC provides guidance for health professionals about other funded contraceptive options.
An alternate brand of levonorgestrel tab 30 mcg has been sourced and listed on the Pharmaceutical Schedule from Wednesday 20 May 2020.
It is was initially listed under section 29 of the Medicines Act. Medsafe has since approved it for sale in New Zealand.
The Pharmaceutical Schedule will not reflect this change until it's updated for 1 July 2020.
Chemical and presentation
Subsidy and price
(ex-man., ex. GST)
Levonorgestrel tab 30 mcg
Microlut SCT S29
- Wastage rules will apply
- The multiple of 28-tab rule applies
The Microlut SCT stock contains four 28-day blisters per original pack. This means that you will need to re-package Microlut SCT into boxes containing three 28-day blisters to fill patient prescriptions.
RxOne users: the new listings have been updated by RxOne. Please refer to the e-Noticeboard on the RxOne Home Screen for instructions if your system has not been updated.
TONIQ users: the new listings have been updated in Toniq medicine databases.
Other contraceptive supply issues
Last updated: 29 May 2020